2
Clinical Trials associated with Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene(Genethon)Phase I/II Clinical Trial of Haematopoietic Stem Cell Gene Therapy for the Wiskott-Aldrich Syndrome
This is a phase I/II study to evaluate the safety and efficacy of Hematopoietic Stem Cell genetherapy for the Wiskott-Aldrich Syndrome.
Phase I/II Clinical Trial of Haematopoietic Stem Cell Gene Therapy for the Wiskott-Aldrich Syndrome
This is a phase I/II study to evaluate the safety and efficacy of Hematopoietic Stem Cell genetherapy for the Wiskott-Aldrich Syndrome.
100 Clinical Results associated with Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene(Genethon)
100 Translational Medicine associated with Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene(Genethon)
100 Patents (Medical) associated with Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene(Genethon)
100 Deals associated with Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene(Genethon)